Regenesis
Cartilage Regeneration through Electrical Stimulations
StartupRegenesis is a Qatsrin-based startup in the Health Tech & Life Sciences sector, established in 2023. Cartilage Regeneration through Electrical Stimulations. The company has 1-10 employees. Core technologies: Biologicals.
The company follows a B2B business model. Product stage: R&D. The company holds 1 patent.
- StagePre-Funding
- ProductR&D
- ModelB2B
- Employees1-10
- HQQatsrin
- DistrictNorth District
- Last RoundUndisclosed
What does Regenesis do?
Regenesis is a biomedical startup aims to revolutionize treatment of cartilage lesions by in situ enhancement of cartilage regeneration. Our innovative solution enables full restoration of the cartilage through a minimally invasive procedure. Regenesis platform is based on a unique biocompatible structure designed to be applied directly or indirectly to the damaged area. The platform can be adopted for tissue regeneration of various medical conditions associated with cartilage damage. The platform can be adopted for tissue regeneration of various medical conditions. The company's portfolio includes include the treatment of hip and ankle lesions and treatment of Osteoarthritis (OA)
What sector is Regenesis in?
Regenesis operates in Health Tech & Life Sciences, Pharma & Medical Biotechnology, Biomaterials & Tissue Engineering, with core technologies in Biologicals. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Regenesis located?
Regenesis is based in Industrial Area, Qatsrin, North District.